Adriana C. H. van Engen–van Grunsven

HRAS-mutated Spitz Tumors

Adriana C. H. van Engen–van Grunsven, Marcory C. R. F. van Dijk, Dirk J. Ruiter et al. · The American Journal of Surgical Pathology · 2010 · 113 citations

Hras Mutation, Spitz Nevus, Tumoral Pathology +15

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

Wim van Boxtel, Laura D. Locati, Adriana C. H. van Engen–van Grunsven et al. · European Journal of Cancer · 2019 · 72 citations

Endocrine Oncology, Medicine, Gynecology +5

NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract—A study of 24 cases from the Netherlands

Adriana C. H. van Engen–van Grunsven, Heidi V.N. Küsters‐Vandevelde, Joanne A. de Hullu et al. · Gynecologic Oncology · 2014 · 47 citations

Urology, Genitourinary Cancer, Surgical Pathology +8

SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas

Heidi V.N. Küsters‐Vandevelde, David Creytens, Adriana C. H. van Engen–van Grunsven et al. · Acta Neuropathologica Communications · 2016 · 45 citations · Full text

[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial

Elizabeth J. de Koster, Lioe‐Fee de Geus‐Oei, Adrienne H. Brouwers et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 42 citations · Full text